Pierre Marie Girard - Concepedia

Author

Pierre Marie Girard

Also Known As

A. Simon, C Lascoux, Christine Katlama, D Beniken), J. Monsonego, J.- P. Viard, L. Ciaffi, M Floridia, M. Parrinello, P GIRARD

100

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Inserm Hôpital Saint-Antoine Assistance Publique – Hôpitaux de Paris Université Paris Cité

About

Pierre Marie Girard is an author at Sorbonne Université specializing in medicine, hiv, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	525
2	Engineering	2	2	45
3	Health Sciences	1	1	22
4	Natural Sciences	1	1	83
5	Public Health	1	1	44

Pierre Marie Girard

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136 Christine Katlama, Marc Antoine Valantin, Michèle Algarté-Génin, AIDS	2010	164
Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion Zhanna SHUTENKO, Yann Henry, Elisabeth Pinard, Biochemical Pharmacology Cerebral Vascular RegulationGlobal IschemiaReperfusion InjuryNitric OxideMedicine	1999	158
Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients Maud Lemoine, Véronique Barbu, Pierre Marie Girard, AIDS	2006	103
IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Martine Gioud-Paquet, M Auvinet, T A Raffin, Annals of the Rheumatic Diseases	1987	88
NO, thiols and disulfides Pierre Marie Girard, Pierre Potìer FEBS Letters Bioorganic ChemistryBiochemistryReactive Nitrogen SpecieNitric OxideNatural Sciences	1993	83
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo, The Lancet HIV Lamivudine Dual TherapySuperiority TrialProtease InhibitorTreatment And PreventionGlobal Health	2017	71
Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV–HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study Anders Boyd, Julie Bottero, Patrick Miailhes, Journal of the International AIDS Society	2017	50
Abnormal free fatty acids and cortisol concentrations in the serum of AIDS patients N. Christeff, Christophe Michon, Guy R. Goertz, European Journal of Cancer and Clinical Oncology Metabolic SyndromeNeurovirologyGlobal HealthHivCortisol Concentrations	1988	46
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies Pierre Frange, Lambert Assoumou, Diane Descamps, Journal of Antimicrobial Chemotherapy Phi PatientsImmunodeficienciesFirst-line StrategiesDrug ResistanceHuman Retrovirus	2015	44
A new synthetic flavonoid protects endothelium-derived relaxing factor-induced relaxation in rabbit arteries in vitro: Evidence for superoxide scavenging Pierre Marie Girard, R. Sercombe, Christine Sercombe, Biochemical Pharmacology Cardiovascular DiseaseMedicineLipid PeroxidationPhysiologyEndothelial Dysfunction	1995	38

Page 1